PDF

Int J Med Sci 2024; 21(1):19-26. doi:10.7150/ijms.88147 This issue Cite

Research Paper

Assessment of renal quality with quantitative contrast-enhanced ultrasound (CEUS) for differentiating kidney histopathology before procurement

Shangxin Dong^1#, Bo Zhang^1#, Zhishui Chen¹, Dunfeng Du¹, Huibo Shi¹, Yuanyuan Zhao¹, Yukun Tang¹, Hongchang Luo^2* , Jipin Jiang^1*

1. Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China.
2. Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
^#Shangxin Dong and Bo Zhang contributed equally to this work.
^*Hongchang Luo and Jipin Jiang contributed equally to this work.

✉ Corresponding authors: Hongchang Luo (Email: liky20006com); Jipin Jiang (Email: jpjiangtjmu.edu.cn).

Abstract

Purpose: This study aimed to investigate the use of contrast-enhanced ultrasonography (CEUS) to assess the kidneys' quality before procurement.

Methods: This prospective study included 74 donors and 148 recipients of kidneys. 119 kidneys underwent quantitative analysis. Before organ procurement, potential kidney donors underwent CEUS, though organ procurement involved a zero-point puncture biopsy. CEUS parameters of the renal cortex and medulla were evaluated, including rise time (RT), time to peak (TTP), the area under the curve (AUC), wash-in slope (WIS), peak intensity (PI), and mean transit time (MTT). Donors' kidneys were classified based on their pathological. Additionally, short-term clinical indicators of renal recipients were collected and analyzed to determine whether the patients had delayed recovery of renal allograft function.

Results: This experiment included 148 cases of kidney information, divided into two groups based on the Remuzzi score of the kidneys. However, 29 kidneys were excluded from the quantitative analysis due to loss or low quality of CEUS images. Comparing the time-intensity curve (TIC) of renal cortical region of interest (ROI), we found that the group with lower pathological scores exhibited higher PI (P=0.002), AUC(P=0.003), and WIS (P=0.009). TIC comparison results for renal medulla ROI revealed that the group with lower pathological scores had higher PI (P=0.010), AUC (P=0.023), and WIS (P=0.024).

Conclusions: This study highlighted the potential of CEUS as a non-invasive, safe, and real-time examination method that correlates with the Remuzzi score and renal pathology. Therefore, it can be used as a prospective preoperative non-invasive evaluation method for the donor's kidney.

Keywords: contrast-enhanced ultrasonography, kidney transplantation, organ procurement, donor selection

Introduction

Kidney transplantation (KT) is regarded as one of the most efficient therapies for patients with end-stage renal failure. Since 2015, organ donation after death has been China's only lawful source of organs[1]. However, due to the acute organ shortage, expanded-criteria donors (ECD) have become a common method of expanding the donor pool[2]. The use of ECD has reduced the waiting time for kidney transplantation. Nevertheless, this method has increased the number of kidneys discarded, thereby wasting human and hospital resources. Although renal biopsy results play an important role in making acceptance decisions, it cannot predict the kidney's quality before procurement, resulting in unnecessary effort. Due to their invasive nature and prolonged cold ischemia time, pre-transplant biopsies increase the risk of potential organ loss, according to several studies[3, 4]. Additionally, renal biopsy results may also be affected by sampling bias[5]. Therefore, there is a need to discover a new method for evaluating renal quality in advance.

Color Doppler ultrasound is a convenient method to evaluate renal perfusion by measuring renal artery flow velocity and resistance index (RI) at the bedside. Contrast-enhanced ultrasonography (CEUS) is a viable alternative to color Doppler ultrasound for assessing the donor kidney's microcirculation perfusion when color Doppler ultrasound fails to do so. CEUS displays real-time perfusion employing microbubble contrast agents and complementary harmonic pulse sequences[6]. The microcirculation perfusion can be accurately reflected by analyzing the area under the curve of the region of interest. Furthermore, the ultrasound contrast agents lack nephrotoxicity and cannot be excreted by the kidneys, making them a safe and appropriate option for assessing renal microcirculation[7]. Currently, CEUS has been utilized in assessing various solid organs, including its application in identifying causes of graft dysfunction after kidney transplantation[8-10]. However, its effectiveness in evaluating the quality of donated kidneys remains uncertain. Before procurement, assessing the quality of marginal donor kidneys remains a formidable obstacle. This study aimed to examine the use of CEUS in evaluating the kidney quality of donors and predicting the results of the zero-point biopsy.

Materials and Methods

Ethics

A total of 148 donated kidneys obtained from October 2021 to October 2022 at Tongji Hospital were included in this study. These donor grafts were donated to the Red Cross Society of Hubei Province and allocated by the China Organ Transplant Response System. This investigation was conducted following China's national organ donation program and per the 2013 Helsinki Declaration[11]. All organ donors included in this study were adults. Exclusion criteria included allergies to contrast agents, hydronephrosis, renal artery stenosis, and malignant tumors. Patients who did not consent to participate were also excluded. The study was approved by the Ethics Committee of Tongji Hospital, affiliated with Tongji Medical College of Huazhong University of Science and Technology (TJ-IRB20220149). Informed consent was obtained from each recipient and each donor's immediate family members.

US and CEUS examinations

Experienced radiologists who were skilled in urologic US and had more than 5 years of CEUS examination experience conducted all US/CEUS examinations on the donors. These doctors lacked access to the clinical and laboratory data of the patients, ensuring a blind study.

We examined prospective donor kidneys at the bedside using CEUS within 24 h before procurement. The patient's blood pressure and the use of vasoactive drugs during the examination were noted. Philips EPIQ7 ultrasonic diagnostic instrument with a c5-1 probe was used for a contrast-enhanced ultrasound examination. The blood pool contrast agent used in this study was SonoVue (Bracco, Milan, Italy), containing sulfur-hexafluoride microbubbles stabilized by a phospholipid shell. Some studies have confirmed the safety of SonoVue[12]. First, both the left and right sides of the kidneys were scanned longitudinally and transversely with conventional US. The renal size, echo, and cortical thickness were recorded. After a typical US examination of the potential donors, we positioned the ultrasonic probe along the kidney's long axis to disclose the renal hilus and maximum kidney area. Then, 1.0 mL of SonoVue was injected via the central venous catheter, followed immediately by an infusion of 5 mL of the saline solution. Image acquisition began at the start of the SonoVue injection and recorded the acquired images on the local hard disk drive in the form of DICOM. During CEUS, the primary gain, focus position, time gain compensation, and other preset parameters remain unchanged. The mechanical index was set at 0.07 (Figure 1).

Image analysis

The perfusion software Sonolive was used to conduct a quantitative analysis of the images. The 'motion compensation' function was enabled to reduce respiration's impact during the analysis. A 4 ^ 2 mm square region of interest (ROI) was placed in the cortex and medulla of the kidney, excluding the interlobar and arcuate arteries (Figure 1). An ROI's signal intensity was measured, and a time-intensity curve (TIC) was generated. Using the following parameters, two TICs were generated for each kidney: rise time (RT), time to peak (TTP), peak intensity (PI), wash-in slope (WIS), the area under the curve (AUC), and mean transit time (MTT). The quantitative ROI parameters of the cortex and medulla were analyzed further.

 Figure 1 

Region of interest selected for quantitative analysis. Region ① is the ROI of the renal cortex. Region ② is the ROI of the renal medulla.

Blood and Histopathological Examinations

Blood samples were collected on the day of the CEUS examination, and all clinical blood tests, including blood routine and renal function, were conducted in the clinical laboratory. After brain death or cardiopulmonary death, confirmed organ donors were determined. The donor's kidney was biopsied during the procurement process at the puncture site. The biopsied tissue is then quickly placed in a formaldehyde solution, embedded in paraffin, and sectioned for hematoxylin-eosin (HE) stains. The Remuzzi score[13] and biopsy histological findings of the donor's kidney should be described. The study revealed several kidney histological findings, including interstitial fibrosis, tubular atrophy, renal interstitial inflammation, arteriolar intimal fibrosis and thickening, arterial hyaline degeneration, intraglomerular thrombosis, and acute renal tubular injury (Table 1).

Statistical analysis

The data were examined using SPSS 26.0 (SPSS lnc., Chicago, USA) software, and demographic and clinical variables were presented as mean value ± standard deviations or median with range. The chi-square test was used to analyze differences between qualitative variables, whereas the one-tailed t-test or Wilcoxon test evaluated differences between quantitative variables. Univariate logistic analysis analyzed all these parameters. P<0.05 is considered statistical significance. By analyzing the ROC curve, the reliability of continuous measurement parameters was calculated. AUROC has been measured and the Youden test has been performed to find out the cut-off to maximize diagnostic accuracy.

Results

Demographics and Baseline Characteristics

Between October 2021 and October 2022, our institution conducted CEUS examinations on both kidneys before surgical procurement for 74 donors after brain death (DBD) or donation after cardiac death (DCD). Biopsies were performed on all donor's kidneys during procurement, yielding pathological information for 148 kidneys. The kidneys were then divided into two groups based on the Remuzzi score: the mild change group (≤ 3 points, n = 74) and the severe change group (≤ 4 points, n = 74). The demographic and clinical characteristics of these two groups are summarized in Table 2. Statistical analysis revealed significant differences in age, Cr, and eGFR between the two groups (Table 2, p < 0.05). The mild change group had higher eGFR and lower Cr levels than the severe change group. Moreover, the mild change group was (P < 0.05). However, there were no significant differences in gender and donor type between the two groups (P > 0.05). During the experiment, no adverse reactions were caused by the ultrasound contrast agent.

The CEUS parameters showed significant differences between the different groups based on histopathological findings

The study utilized the Remuzzi score to classify the CEUS parameters into mild and severe change groups. Each kidney was analyzed for two TICs, including cortical and medullary TICs. However, 29 kidneys were excluded from the quantitative analysis due to image loss or poor quality. The mild change group comprised 61 cases, while the severe change group included 60 cases. The study found no significant differences in RTc, MTTc, and TTPc between both groups when comparing the CEUS parameters of renal cortex ROI (P > 0.05). However, there was a significant difference in PIc, AUCc, and WISc between the two groups (P < 0.05), as shown in Table 3. Additionally, when comparing the CEUS parameters of the renal medulla ROI, no significant difference was found in RTm, MTTm, and TTPm between the two groups (Table 3, P > 0.05). However, both groups significantly differed in PIm, AUCm, and WISm (Table 3, P < 0.05).

This study examined the relationship between CEUS parameters and renal pathology. We divided the parameters based on the specific pathological manifestation to analyze the data. Renal interstitial fibrosis and renal tubular atrophy were categorized into normal and mild groups. Similarly, arteriolar intimal fibrosis and arteriolar hyalinosis were divided into two groups. The first group included normal and mild cases, while the second included moderate and severe cases. Significant differences were found between the two groups based on renal interstitial fibrosis regarding AUCc and MTTm (P < 0.05). In the normal group, AUCc values were larger (680.46 VS 592.51 dB*s, P = 0.032), and MTTm was longer (27.11 VS 24.15 s, P = 0.048). Furthermore, renal tubular atrophy was found to be correlated with AUCc and MTTm, showing larger AUCc (660.67 VS 578.26 dB*s, P = 0.033) and longer MTTm (26.74 VS 23.17 s, P = 0.020) in the normal group. The CEUS parameters analysis based on the arteriolar intimal fibrosis grouping revealed that the mild change group had faster TTPm (21.23 s VS 24.70 s, P = 0.036). Comparing the parameters of CEUS based on the grouping of arteriolar hyalinosis, it was found that the group with mild changes had faster RTc (6.55 VS 7.70 s, P = 0.045), TTPc (15.82 s VS 19.44 s, P=0.011), and TTPm (19.90 VS 24.66 s, P = 0.004).

CEUS parameters have significant correlation with Remuzzi score

This study utilized logistic regression analysis to determine which parameters of CEUS accurately predicted the severity of pathological conditions. Table 5 demonstrates that according to univariate logistic regression analysis, PIc, AUCc, WISc, PIm, AUCm, and WISm were all significantly associated with the severity of renal pathology (P < 0.05).

The study found that the AUROC of WISc was 0.617 (Table 6), while the PIc AUROC was 0.668 (Figure 2). The AUROC for the area under the TIC of the renal cortex ROI was 0.646, and the PIm AUROC was 0.632 (Figure 3). Additionally, the AUROC for the area under the TIC of the renal medulla ROI was 0.610. The PIc cutoff (Youden index) of 14.75 dB was determined based on the highest sensitivity (51.7%) and specificity (79.7%) for discriminating between the mild and severe change groups.

 Figure 2 

The ROC of renal cortex parameters. The AUC of WISc is 0.617. The AUC of PIc is 0.668. The AUC of AUCc is 0.646.

CEUS parameters have no significant difference between delayed graft function (DGF) group and normal group

To examine the correlation between CEUS parameters and the recovery of renal allograft function after surgery, we gathered postoperative clinical data from patients at our institution. Fourteen kidneys involved in dual or combined organ transplants were excluded. However, the DGF group comprised the patients whose serum creatinine value did not drop below 400umol/L in the first postoperative week and required hemodialysis intervention[14]. Patients with normal renal allograft function comprised the normal group, and CEUS parameters were compared between the normal and abnormal renal allograft function groups. As shown in Table 7, no statistically significant differences were observed between the two groups.

 Figure 3 

The ROC of renal medulla parameters. The AUC of WISm is 0.599. The AUC of PIm is 0.632. The AUC of AUCm is 0.610.

Discussion

The most widely used method for evaluating the quality of kidney grafts is the Kidney Donor Profile Index (KDPI). Studies have shown a negative correlation between KDPI and graft survival rate[15, 16]. The relationship between procurement biopsy results and transplantation results is still uncertain. A Systematic review on the prediction of transplantation results from donor kidney biopsy results found that there was no consistent relationship between donor biopsy results and transplantation results[17]. Nevertheless, purchasing biopsy results still plays an important role in determining whether the kidney is accepted[18]. The histological information of the donor kidney is often used to determine the rejection, allocation, and whether to undergo dual kidney transplantation.

CEUS facilitates objective quantitative and comparative analysis of organ tissue perfusion. Using CEUS parameters and pathological data from the donor's kidneys, significant differences in PIc, AUCc, WISc, PIm, AUCm, and WISm were observed between pathological groups. Additionally, univariate logistic regression analysis revealed that AUCc, TTPc, MTTm, and TTPm were significantly associated with renal pathology severity (P < 0.05). The mean values of PI, AUC, and WIS for the Remuzzi score were greater in the mild change group than in the severe change group. Also investigated was the correlation between CEUS parameters and short-term graft function recovery in renal transplant recipients. Following the operation, patient clinical data were collected, and renal transplant patients were categorized as DGF and normal groups. Our study found no significant differences between the two groups in terms of CEUS parameters. However, a strong correlation between CEUS, Remuzzi scores, and renal pathology has been observed. Thus, it indicates that CEUS has the potential to be used as a non-invasive method for evaluating donor kidney preoperative assessment.

ROC curves were generated to evaluate the diagnostic value of ultrasound contrast parameters associated with the Remuzzi score. The diagnostic threshold for the optimal indicator PIc was calculated and found to be 14.75 dB, indicating that PIc values below this cutoff could benefit diagnosis. In the mild and severe change groups, a sensitivity of 51.7% and a specificity of 79.2% were observed. Although the current diagnostic efficacy of CEUS parameters cannot fully replace histopathology examination, it remains a promising non-invasive technology for assessing donor kidneys' quality before procurement.

Quantitative CEUS has been investigated to distinguish histopathological damage following renal transplantation. In Eva Vi's study, transplanted kidneys were categorized according to the Banff classification, including the minimal change and significant injury groups[19]. After analyzing the CEUS parameters of the two groups, it was determined that the difference in time to peak between the medulla and cortex (TTP m-c) is an effective diagnostic tool for predicting severe pathological damage to transplanted kidneys. In a recent investigation on donor livers, 67 were examined using CEUS before surgical procurement. Of these,15 livers (22.4%) were discarded, while 52 (77.6%) were deemed transplantable[20]. According to multivariate analysis, a decrease in enhancement (OR = 2.588, 95% CI: 1.234-5.426, P = 0.012) was an independent factor for liver discard. Furthermore, a study that utilized quantitative parameters of CEUS to evaluate the pathology of chronic kidney disease found that the average values of PI and AUC decreased as the severity of the disease increased[21]. The study found no correlation between RT and WIS with kidney pathology (P > 0.05). However, another investigation revealed that CEUS parameters such as peak enhancement, wash-in and wash-out AUC were substantially different between patients with diabetes nephropathy (DN) and those with non-diabetes renal disease (NDRD). It was identified during a CEUS evaluation of renal microcirculation perfusion in patients with renal injury and diabetes[22]. Peak enhancement and AUC may be potential parameters to differentiate DN.

Therefore, further research is required to provide additional evidence. CEUS is generally a promising screening tool for marginal donor kidneys. Predicting kidney quality using CEUS is critically essential for organ acquisition. Currently, renal puncture biopsy is the most accurate technique for assessing kidney health[23]. However, the cost of rejecting kidneys due to substandard quality after acquisition raises the manpower and material costs associated with organ procurement. Prior knowledge of kidney pathology and preoperative evaluation can improve resource allocation and decrease acquisition costs.

This research has limitations that must be acknowledged. First, although experienced ultrasound physicians performed CEUS, the consistency between observers was not evaluated by two independent technicians. Second, no kidneys were discarded in this study due to inadequate quality, and no donor's kidneys were discarded for comparison. Third, during TIC analysis, the patient's respiration can significantly interfere with the parameters, particularly when the ROI receives signals from small arteries. Additionally, the use of vasoactive drugs in the ICU before surgery by most potential dead donors can affect the results of CEUS.

In conclusion, this study found a correlation between renal PI, AUC, and WIS and renal pathology. CEUS is indicated as a potential technique for evaluating renal pathology prior to surgery.

Acknowledgements

Funding

This study work was supported by grants from the Health Commission of Hubei Province (funder: ZS.C; funding Grant NO: WJ2021C001) and Key Research and Development Plan of Hubei Province (funder: ZS.C; funding Grant NO: 2022BCA015).

Author contributions

D.D. conceived the research, collected data, and wrote the manuscript. B.Z. helped with data interpretation. Z.C. assisted with experimental design. D.D. assisted with mapping. H.S. assisted with data collection. Y.Z. revised the manuscript. Y.T. assisted with sample collection. J.J. conceived the research, designed the experiments, and supervised the research. H.L. assisted with experimental design and performed contrast-enhanced ultrasound examination on the donor.

Competing Interests

The authors have declared that no competing interest exists.

References

1. Huang J, Millis JM, Mao Y, Millis MA, Sang X, Zhong S. Voluntary organ donation system adapted to Chinese cultural values and social reality. Liver Transpl. 2015;21:419-22

2. Stratta RJ, Harriman D, Gurram V, Gurung K, Sharda B. Dual kidney transplants from adult marginal donors: Review and perspective. Clin Transplant. 2022;36:e14566

3. Jadav P, Mohan S, Husain SA. Role of deceased donor kidney procurement biopsies in organ allocation. Curr Opin Nephrol Hypertens. 2021;30:571-6

4. Girolami I, Gambaro G, Ghimenton C, Beccari S, Caliò A, Brunelli M. et al. Pre-implantation kidney biopsy: value of the expertise in determining histological score and comparison with the whole organ on a series of discarded kidneys. J Nephrol. 2020;33:167-76

5. Leung G, Kirpalani A, Szeto SG, Deeb M, Foltz W, Simmons CA. et al. Could MRI Be Used To Image Kidney Fibrosis? A Review of Recent Advances and Remaining Barriers. Clin J Am Soc Nephrol. 2017;12:1019-28

6. Muskiet MHA, Emanuel AL, Smits MM, Tonneijck L, Meijer RI, Joles JA. et al. Assessment of real-time and quantitative changes in renal hemodynamics in healthy overweight males: Contrast-enhanced ultrasonography vs para-aminohippuric acid clearance. Microcirculation. 2019;26:e12580

7. Copur S, Yavuz F, Sag AA, Tuttle KR, Kanbay M. Future of kidney imaging: Functional magnetic resonance imaging and kidney disease progression. Eur J Clin Invest. 2022;52:e13765

8. Gürbüz AF, Keven A, Elmalı A, Toru S, Apaydın A, Çeken K. A comparison between the superb microvascular imaging technique and conventional Doppler ultrasound in evaluating chronic allograft damage in renal transplant recipients. Diagn Interv Radiol. 2023;29:212-8

9. Tufano A, Drudi FM, Angelini F, Polito E, Martino M, Granata A. et al. Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Renal Masses with Histopathological Validation-Results from a Prospective Single-Center Study. Diagnostics (Basel). 2022 12

10. Drudi FM, Valentino M, Bertolotto M, Malpassini F, Maghella F, Cantisani V. et al. CEUS Time Intensity Curves in the Differentiation Between Leydig Cell Carcinoma and Seminoma: A Multicenter Study. Ultraschall Med. 2016;37:201-5

11. Fang X, Chen S, Fu J, Liu R, Dai T, Wang D. et al. Risk factors for renal allograft survival with China novel donation category: Donation after brain death followed by cardiac arrest. Transpl Immunol. 2022;72:101591

12. Hu C, Feng Y, Huang P, Jin J. Adverse reactions after the use of SonoVue contrast agent: Characteristics and nursing care experience. Medicine (Baltimore). 2019;98:e17745

13. Remuzzi G, Grinyò J, Ruggenenti P, Beatini M, Cole EH, Milford EL. et al. Early experience with dual kidney transplantation in adults using expanded donor criteria. Double Kidney Transplant Group (DKG). J Am Soc Nephrol. 1999;10:2591-8

14. Hu XJ, Zheng J, Li Y, Tian XH, Tian PX, Xiang HL. et al. Prediction of kidney transplant outcome based on different DGF definitions in Chinese deceased donation. BMC Nephrol. 2019;20:409

15. Hariharan S, Israni AK, Danovitch G. Long-Term Survival after Kidney Transplantation. N Engl J Med. 2021;385:729-43

16. Jun H, Jung CW, Lim S, Kim MG. Kidney Donor Risk Index as the Predictor for the Short-term Clinical Outcomes After Kidney Transplant From Deceased Donor With Acute Kidney Injury. Transplant Proc. 2017;49:88-91

17. Wang CJ, Wetmore JB, Crary GS, Kasiske BL. The Donor Kidney Biopsy and Its Implications in Predicting Graft Outcomes: A Systematic Review. Am J Transplant. 2015;15:1903-14

18. Schantz K, Gordon EJ, Lee U, Rocha M, Friedewald J, Ladner DP. et al. The Role of Procurement Biopsies in Kidney Acceptance Decision Making and Kidney Discard: Perceptions of Physicians, Nurse Coordinators, and OPO Staff and Directors. Transplant Direct. 2022;8:e1299

19. Vičič E, Kojc N, Hovelja T, Arnol M, Ključevšek D. Quantitative contrast-enhanced ultrasound for the differentiation of kidney allografts with significant histopathological injury. Microcirculation. 2021;28:e12732

20. Zhang HJ, Zheng BW, Gu SJ, Wu T, Wu LL, Lian YF. et al. Doppler ultrasonography and contrast-enhanced ultrasonography to evaluate liver allograft discard: A pilot prospective study. Clin Hemorheol Microcirc. 2021;77:107-14

21. Yang WQ, Mou S, Xu Y, Xu L, Li FH, Li HL. Quantitative parameters of contrast-enhanced ultrasonography for assessment of renal pathology: A preliminary study in chronic kidney disease. Clin Hemorheol Microcirc. 2018;68:71-82

22. Wang Y, Li N, Tian X, Lin L, Liang S, Zhao P. et al. Evaluation of Renal Microperfusion in Diabetic Patients With Kidney Injury by Contrast-Enhanced Ultrasound. J Ultrasound Med. 2021;40:1361-8

23. Naesens M. Zero-Time Renal Transplant Biopsies: A Comprehensive Review. Transplantation. 2016;100:1425-39

Author contact

Corresponding authors: Hongchang Luo (Email: liky20006com); Jipin Jiang (Email: jpjiangtjmu.edu.cn).

Received 2023-7-16
Accepted 2023-10-14
Published 2024-1-1

Citation styles

©2024 Ivyspring International Publisher. Terms of use